ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279

ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279 on “Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agents”. Our team contributes to the CRC with a project on hyperpolarized nanodiamond as contrast agents for cancer research. Funded initially for a period of 4 years the CRC may be extended for a duration of up to 12 years.

https://www.uni-ulm.de/med/fakultaet/med-detailseiten/news-detail/article/rund-121-millionen-neuer-peptid-sonderforschungsbereich-koerpereigene-wirkstoffe-gegen-hiv/

Most Recent Papers

On quantum gravity tests with composite particles, Nature Communications 11 (2020) 3900

Temporal correlations of sunlight may assist photoprotection in bacterial photosynthesis, New Journal of Physics 22 (2020) 073042

A Complex Comprising a Cyanine Dye Rotaxane and a Porphyrin Nanoring as a Model Light‐Harvesting System, Angewandte Chemie, Int. Ed. 59 (2020) 1

Contact

Ulm University
Institute of Theoretical Physics
Albert-Einstein-Allee 11
D - 89069 Ulm
Germany

Tel: ++49 / 731 / 50 - 22911
Fax: ++49 / 731 / 50 - 22924

Office: Building M26, room 4117

Click here if you are interested in applying to the group